[go: up one dir, main page]

AU2002224046A1 - Nootropic effect enhancer - Google Patents

Nootropic effect enhancer

Info

Publication number
AU2002224046A1
AU2002224046A1 AU2002224046A AU2404602A AU2002224046A1 AU 2002224046 A1 AU2002224046 A1 AU 2002224046A1 AU 2002224046 A AU2002224046 A AU 2002224046A AU 2404602 A AU2404602 A AU 2404602A AU 2002224046 A1 AU2002224046 A1 AU 2002224046A1
Authority
AU
Australia
Prior art keywords
effect enhancer
nootropic effect
nootropic
enhancer
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224046A
Inventor
Nobuya Matsuoka
Kenichi Tokita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU2002224046A1 publication Critical patent/AU2002224046A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU2002224046A 2000-12-07 2001-11-16 Nootropic effect enhancer Abandoned AU2002224046A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000373260 2000-12-07
JP2000-373260 2000-12-07
PCT/JP2001/010068 WO2002045715A1 (en) 2000-12-07 2001-11-16 Nootropic effect enhancer

Publications (1)

Publication Number Publication Date
AU2002224046A1 true AU2002224046A1 (en) 2002-06-18

Family

ID=18842674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224046A Abandoned AU2002224046A1 (en) 2000-12-07 2001-11-16 Nootropic effect enhancer

Country Status (6)

Country Link
US (2) US20040029894A1 (en)
EP (1) EP1340499A4 (en)
JP (1) JPWO2002045715A1 (en)
AU (1) AU2002224046A1 (en)
CA (1) CA2431181A1 (en)
WO (1) WO2002045715A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002045715A1 (en) * 2000-12-07 2004-04-08 藤沢薬品工業株式会社 Anti-dementia effect enhancer
JPWO2003047625A1 (en) * 2001-12-07 2005-04-14 知之 西崎 Neurotransmitter
KR101517414B1 (en) * 2014-04-24 2015-05-04 고려대학교 산학협력단 A composition for prevention and treatment of inflammatory diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
US5250528A (en) * 1989-08-02 1993-10-05 Fujisawa Pharmaceutical Co., Ltd. New aminopiperazine derivatives
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ATE204264T1 (en) * 1993-06-18 2001-09-15 Fujisawa Pharmaceutical Co INTERMEDIATE PRODUCT FOR USE IN SYNTHESIS AND METHOD FOR PRODUCING AN AMINOPIPERAZINE DERIVATIVE
AT403803B (en) * 1996-04-19 1998-05-25 Sanochemia Ltd NEW BENZAZEPINE DERIVATIVES, THESE MEDICINAL PRODUCTS AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS
ZA9710872B (en) * 1996-12-12 1998-06-15 Fujisawa Pharmaceutical Co N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate.
KR20000057303A (en) * 1996-12-24 2000-09-15 후지야마 아키라 New use of aminopiperazine derivatives
WO1999019315A1 (en) * 1997-10-09 1999-04-22 Fujisawa Pharmaceutical Co., Ltd. New process for producing aminopiperazine derivatives
AUPP818099A0 (en) * 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
US6344358B1 (en) * 1999-05-28 2002-02-05 Fujisawa Pharmaceutical Co., Ltd. Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
GB0021885D0 (en) * 2000-09-06 2000-10-18 Fujisawa Pharmaceutical Co New use
JPWO2002045715A1 (en) * 2000-12-07 2004-04-08 藤沢薬品工業株式会社 Anti-dementia effect enhancer
JP2003063992A (en) * 2001-08-28 2003-03-05 Fujisawa Pharmaceut Co Ltd AGENT FOR SPECIFICALLY INCREASING ELECTRIC CURRENT IN N- TYPE Ca2+ CHANNEL

Also Published As

Publication number Publication date
EP1340499A4 (en) 2006-05-03
WO2002045715A1 (en) 2002-06-13
US20060074091A1 (en) 2006-04-06
CA2431181A1 (en) 2002-06-13
EP1340499A1 (en) 2003-09-03
US20040029894A1 (en) 2004-02-12
JPWO2002045715A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2001234470A1 (en) Cardiac-cell specific enhancer elements and uses thereof
AU2001292739A1 (en) 1-oxorapamycins
AU2002211620A1 (en) Autoanastomosis
AU2001254546A1 (en) Aminopiperidines
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001265089A1 (en) Rc-timer scheme
AU2001258349A1 (en) Bisacylguanidine
AU2001252971A1 (en) Tiller
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001258924A1 (en) Microsatellite-aflp
AU2001254731A1 (en) Substituted phenyluracils
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2002224046A1 (en) Nootropic effect enhancer
AU2002223604A1 (en) Substituted phenyluracils
AU2001260192A1 (en) Glycinamides
AU2001284173A1 (en) Calycins
AU2001262711A1 (en) Cytoprotectors
AU2001295713A1 (en) Blast-processing